Who Qualifies for Obesity Medication? Key Criteria

By GOAL.MD Team — November 10, 2026

Who qualifies for obesity medication? See how BMI, medical history, safety, and clinician review guide a personalized weight loss treatment plan today.

A number on the scale is rarely the whole story. For adults asking who qualifies for obesity medication, the answer typically begins with body mass index (BMI), but it also includes health history, weight-related conditions, current medications, and whether treatment can be used safely. The right program is not about chasing a quick fix. It is about choosing a physician-supervised plan designed around your health, goals, and long-term progress.

Prescription weight loss medications, including GLP-1-based options, can help eligible patients reduce appetite, improve metabolic health, and support meaningful weight loss alongside nutrition, activity, sleep, and other lifestyle foundations. A licensed clinician should determine whether medication is appropriate for you.

Who qualifies for obesity medication under standard criteria?

Most FDA-approved chronic weight management medications are prescribed to adults who meet one of two common BMI thresholds. You may be a candidate if you have a BMI of 30 or higher, which falls within the clinical range for obesity. You may also qualify with a BMI of 27 or higher if you have at least one weight-related medical condition.

Those conditions can include high blood pressure, high cholesterol, prediabetes or type 2 diabetes, obstructive sleep apnea, cardiovascular disease, or certain weight-related mobility concerns. These criteria reflect an important clinical reality: excess weight can affect more than appearance. It can influence energy, sleep, metabolic markers, joint comfort, and long-term health risk.

BMI is a useful screening tool, not a complete picture of health. It does not account for every factor, including body composition, ethnicity, muscle mass, or where the body stores fat. Your clinician may consider those details, along with your lab work, symptoms, and health goals, when deciding whether a prescription treatment plan makes sense.

A qualifying BMI is the starting point, not an automatic approval

Meeting a BMI threshold does not guarantee that a particular medication is right for you. FDA-approved weight management therapies have individual prescribing information, dose schedules, expected effects, and safety considerations. One person may be well suited to a GLP-1 medication, while another may need a different strategy or should avoid medication entirely.

A thoughtful evaluation also looks at your previous efforts. If you have consistently tried to lose weight through nutrition changes, exercise, commercial programs, or other methods without achieving sustainable results, that history is clinically relevant. Obesity is a complex chronic condition, not a personal failure or a lack of willpower. For many people, physician-guided medication can be a valuable addition to a broader care plan.

Health history matters as much as BMI

Your clinician will review your medical history before recommending treatment. This includes current and past conditions, surgical history, family history, allergies, pregnancy plans, and every medication or supplement you take. Transparency matters here. Even treatments that seem unrelated to weight loss can affect which options are appropriate.

For example, a patient with type 2 diabetes may benefit from a medication that also supports blood sugar management, but may need closer monitoring if they use insulin or certain diabetes medications. Someone with high blood pressure may need a different approach than someone with a history of heart rhythm concerns. The goal is to match treatment to your complete clinical profile rather than prescribe based on BMI alone.

Your provider may also request recent lab results or recommend baseline testing. Depending on your history, this may include markers such as blood sugar, cholesterol, kidney function, liver function, or thyroid status. These details help establish a clear starting point and identify issues that deserve attention during treatment.

When obesity medications may not be appropriate

There are circumstances where a clinician may advise against a weight loss medication, recommend further evaluation, or select a different option. Pregnancy and breastfeeding are key examples. Weight loss medications are generally not used during pregnancy, and patients planning a pregnancy should discuss timing and medication discontinuation with their clinician.

Some GLP-1-based medications may not be appropriate for people with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2. A history of pancreatitis, significant digestive disease, gallbladder problems, severe kidney issues, or certain eating disorders may also change the risk-benefit discussion.

This does not mean every condition is an automatic disqualification. It means treatment should be individualized. A physician-supervised evaluation creates space to weigh potential benefits against side effects, interactions, and your broader health priorities.

What happens during a physician-supervised evaluation?

A quality telehealth consultation should feel more comprehensive than checking a box for a prescription. The clinician will typically review your weight history, current weight and height, medical conditions, medications, and treatment goals. They may ask about appetite patterns, sleep, stress, activity level, prior dieting experiences, and symptoms that could point to an underlying medical issue.

The conversation should also cover realistic expectations. Medication can be highly effective for eligible patients, but results vary. Some people experience substantial weight loss and improved metabolic markers. Others may have slower progress, need dose adjustments, or find that a particular therapy does not agree with them. Common side effects with GLP-1 medications can include nausea, constipation, diarrhea, or reduced appetite, especially while the dose is being increased.

A responsible plan includes ongoing monitoring, not just an initial prescription. Follow-up visits allow your clinician to review your response, manage side effects, adjust treatment when appropriate, and make sure your plan remains aligned with your health. Telehealth can make that continuity more convenient by bringing physician-guided care and prescription delivery to your door when clinically appropriate.

Clinical eligibility and insurance coverage are different questions

You can qualify medically for obesity medication and still face limitations with insurance coverage. Plans vary widely in whether they cover chronic weight management medications, which diagnoses they require, and what prior authorization steps apply. Some plans exclude these medications altogether.

For patients who prefer a more direct path, cash-pay telehealth programs can offer transparent access to a clinical evaluation and personalized treatment plan without the repeated friction of traditional appointments. Coverage should never determine whether your health concerns are valid, but it can affect how you choose to pay for care.

How to prepare for your consultation

Come prepared to discuss your health clearly and accurately. Have your current weight, height, medication list, known diagnoses, allergies, and recent lab results available if you have them. Be ready to share past weight loss attempts and any side effects or concerns you have had with previous medications.

It also helps to define what progress means to you. That may be improving blood sugar, sleeping better, moving with more comfort, reducing health risks, or feeling more in control around food. A strong treatment plan is built around measurable outcomes that matter beyond the scale.

If you meet the typical BMI criteria, have a weight-related health condition, or simply want a clinical opinion after struggling to make lasting progress, a physician consultation is the right next step. The most effective path is not the fastest prescription. It is the one that gives you a safe, personalized foundation for results you can maintain.

Medically reviewed by Dr. Michael Mimlitz, MD (NPI 1508891870), Chief Physician of GOAL.MD. Physician-supervised telehealth. More at goal.md/blog.